Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020

  • ID: 3978153
  • Report
  • Region: Global
  • 87 pages
  • P&S Market Research
1 of 3
The global muscle relaxant drugs market is expected to grow with a CAGR of 5.5% during 2015 - 2020. Based on type, the global muscle relaxant drugs market was dominated by the facial aesthetic relaxant segment in 2014.

The global market of muscle relaxants is growing due to increase in geriatric population, increasing prevalence of skin diseases and harmful effects of ultra violet radiation. Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. Muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.

Moreover, the geriatric population is also more prone to musculoskeletal problems, compared to adults. This is due to the weakening of their muscles, which causes pains, cramps, and other muscle related problems. For the management of these aged-related musculoskeletal problems, people use prescription-based, as well as over-the-counter (OTC) drugs including muscle relaxants for their management. Thus, the growing geriatric population is fuelling the growth of the global muscle relaxants drugs market.

Moreover, the increasing usage of neuromuscular blocking agents in surgeries, and increase in disposable income are also driving the growth of the global muscle relaxant drugs market. The neuromuscular blocking agents are used in the post-operative anesthetic practices. Moreover, the administration of neuromuscular blocking agents is the initial step of the surgeries.

The usage of neuromuscular blocking agents in the operating room is quite common and holds importance in the surgeries. The neuromuscular blockers are administered to anesthetized patients for providing relaxation of skeletal muscles. Moreover, they are valuable adjuncts to general anesthetics and facilitate surgeons to perform surgeries.

The restraints associated with the growth of the global muscle relaxant drugs market include high capital expenditure, stringent regulatory requirements, and risks associated with muscle relaxants. The tradition of online shopping for the muscle relaxant drugs and increasing usage of muscle relaxant drugs in the cosmetic industry are major trends observed in the global muscle relaxant drugs market.

Geographically, North America is expected to maintain its dominance in the global market of muscle relaxants drugs during 2015-2020. This is due to due to increased awareness about various types of musculoskeletal problems and their management, aging population, and increasing number of saloon and spas in the region. In addition, the increasing R&D investments and improved healthcare infrastructure are also driving the growth of market in the region.

The Asian market of muscle relaxant drugs is expected to witness the highest growth globally, during the forecast period. This is mainly due to aging population, increasing number of surgeries, and improving healthcare infrastructure. According to the UN publication, World Population Ageing 2013, in Asia approximately 468.5 million people belonged to the age group of 60 years and above, out of which approximately 57.5 million people were aged 80 years and above.

The key companies operating in the global muscle relaxant drugs market include F. Hoffmann-La Roche Ltd, Johnson & Johnson, GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Pfizer Inc., Galderma S.A., and Merck & Co. Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Research Scope & Methodology
1.1 Market Definition
1.2 Objective
1.3 Market Scope
1.3.1 Market Breakdown By Type
1.3.2 Market Breakdown By Drugs
1.3.3 Market Breakdown By Geography
1.4 Research Methodology And Sources

2. Executive Summary
2.1 Key Findings
2.2 Research Summary

3. Market Outlook
3.1 Introduction
3.1.1 Applications Of Muscle Relaxants
3.1.1.1 Applications Of Muscle Relaxants In Musculoskeletal Problems
3.1.1.2 Uses Of Muscle Relaxants In Anesthesia
3.1.1.3 Applications Of Muscle Relaxants In Facial Aesthetics
3.2 Trends In The Muscle Relaxant Market
3.2.1 Growing Online Retailing Of Muscle Relaxant Drugs
3.2.2 Increasing Popularity Of Muscle Relaxant Treatments In The Cosmetic Industry
3.3 Factors Driving Growth Of The Market And Its Impact On Market Forecast
3.3.1 Growing Geriatric Population
3.3.2 Increasing Prevalence Of Skin Diseases And Harmful Effects Of Ultra-Violet Radiation
3.3.3 Increasing Usage Of Neuromuscular Blocking Agents In Surgeries
3.3.4 Increase In Disposable Income Leading To Increase In Spends On Facial Aesthetic Therapies
3.3.5 Impact Analysis Of Drivers On Market Forecast
3.4 Factors Hindering Growth Of The Market And Its Impact On Market Forecast
3.4.1 High Capital Expenditure
3.4.2 Stringent Regulatory Requirements
3.4.3 Risks Associated With Muscle Relaxants
3.4.4 Impact Analysis Of Restraints On Market Forecast

4. Global Muscle Relaxant Drugs Market Size And Forecast (2011-2020)
4.1 Global Muscle Relaxant Drugs Market, By Type
4.2 Global Muscle Relaxant Drugs Market, By Geography

5. Global Muscle Relaxant Drugs Market, By Type
5.1 Facial Aesthetic Relaxants Market
5.1.1 Facial Aesthetic Muscle Relaxants Market, By Region
5.1.2 Facial Aesthetic Muscle Relaxants Market, By Drug
5.2 Skeletal Muscle Relaxants Market
5.2.1 Skeletal Muscle Relaxants Market, By Geography
5.2.2 Skeletal Muscle Relaxants Market, By Drug
5.3 Neuromuscular Blocking Agents Market
5.3.1 Neuromuscular Blocking Agents Market, By Geography
5.3.2 Neuromuscular Blocking Agents Market, By Type

6. Global Muscle Relaxant Drugs Market, By Geography
6.1 North America Muscle Relaxant Drugs Market
6.1.1 North America Muscle Relaxant Drugs Market, By Type
6.1.2 North America Muscle Relaxant Drugs Market, By Country
6.2 Europe Muscle Relaxant Drugs Market
6.2.1 Europe Muscle Relaxant Drugs Market, By Type
6.2.2 Europe Muscle Relaxant Drugs Market, By Country
6.3 Asia Muscle Relaxant Drugs Market
6.3.1 Asia Muscle Relaxant Drugs Market, By Type
6.3.2 Asia Muscle Relaxant Drugs Market, By Country
6.4 Rest Of The World Muscle Relaxant Drugs Market
6.4.1 Row Muscle Relaxant Drugs Market, By Type

7. Drug Approval Process In The U.S. And Eu
7.1 Drug Approval Process In The U.S.
7.2 Drug Approval Process In The Eu

8. Competitive Positioning And Market Share Analysis
8.1 Porter's Five Forces Of Competitive Position Analysis
8.1.1 Bargaining Power Of Buyers
8.1.2 Bargaining Power Of Suppliers
8.1.3 Threat Of New Entrants
8.1.4 Intensity Of Rivalry
8.1.5 Threat Of Substitutes
8.2 Global Muscle Relaxant Drugs Market Share Analysis

9. Company Profiles And Strategic Developments
9.1 Key Company Profiles
9.1.1 F. Hoffmann-La Roche Ltd
9.1.1.1 Business Overview
9.1.1.2 Product And Service Offerings
9.1.2 Johnson & Johnson
9.1.2.1 Business Overview
9.1.2.2 Product And Service Offerings
9.1.3 Glaxosmithkline Plc
9.1.3.1 Business Overview
9.1.3.2 Product Offerings
9.1.4 Intas Pharmaceuticals Ltd.
9.1.4.1 Business Overview
9.1.4.2 Product Offerings
9.1.5 Pfizer Inc.
9.1.5.1 Business Overview
9.1.5.2 Product Offerings
9.1.6 Galderma S.A.
9.1.6.1 Business Overview
9.1.6.2 Product Offerings
9.1.7 Merck & Co., Inc.
9.1.7.1 Business Overview
9.1.7.2 Product Offerings
9.2 Strategic Developments In The Muscle Relaxant Drugs Market

10. Appendix
10.1 List Of Abbreviations

List Of Tables
Table 1 Specific Primary And Secondary Sources Used For This Publication
Table 2 Global Muscle Relaxant Drugs Market Snapshot
Table 3 Drivers For The Market: Impact Analysis
Table 4 Restraints For The Market: Impact Analysis
Table 5 Global Muscle Relaxant Drugs Market Breakdown By Type, $M (2011-2014)
Table 6 Global Muscle Relaxant Drugs Market Breakdown By Type, $M (2015-2020)
Table 7 Global Muscle Relaxant Drugs Market Breakdown By Geography, $M (2011-2014)
Table 8 Global Muscle Relaxant Drugs Market Breakdown By Geography, $M (2015-2020)
Table 9 Global Facial Aesthetic Muscle Relaxants Market Breakdown By Geography, $M (2011-2014)
Table 10 Global Facial Aesthetic Muscle Relaxants Market Breakdown By Geography, $M (2015-2020)
Table 11 Global Facial Aesthetic Muscle Relaxants Market Breakdown By Drug, $M (2011-2014)
Table 12 Global Facial Aesthetic Muscle Relaxants Market Breakdown By Drug, $M (2015-2020)
Table 13 Global Skeletal Muscle Relaxants Market Breakdown By Geography, $M (2011-2014)
Table 14 Global Skeletal Muscle Relaxants Market Breakdown By Geography, $M (2015-2020)
Table 15 Global Skeletal Muscle Relaxants Market Breakdown By Drug, $M (2011-2014)
Table 16 Global Skeletal Muscle Relaxants Market Breakdown By Drug, $M (2015-2020)
Table 17 Global Neuromuscular Blocking Agents Market Breakdown By Geography, $M (2011-2014)
Table 18 Global Neuromuscular Blocking Agents Market Breakdown By Geography, $M (2015-2020)
Table 19 Global Neuromuscular Blocking Agents Market Breakdown By Type, $M (2011-2014)
Table 20 Global Neuromuscular Blocking Agents Market Breakdown By Type, $M (2015-2020)
Table 21 North America Muscle Relaxant Drugs Market Breakdown By Type, $M (2011-2014)
Table 22 North America Muscle Relaxant Drugs Market Breakdown By Type, $M (2015-2020)
Table 23 North America Muscle Relaxant Drugs Market Breakdown By Country, $M (2011-2014)
Table 24 North America Muscle Relaxant Drugs Market Breakdown By Country, $M (2015-2020)
Table 25 Europe Muscle Relaxant Drugs Market Breakdown By Type, $M (2011-2014)
Table 26 Europe Muscle Relaxant Drugs Market Breakdown By Type, $M (2015-2020)
Table 27 Europe Muscle Relaxant Drugs Market Breakdown By Country, $M (2011-2014)
Table 28 Europe Muscle Relaxant Drugs Market Breakdown By Country, $M (2015-2020)
Table 29 Asia Muscle Relaxant Drugs Market Breakdown By Type, $M (2011-2014)
Table 30 Asia Muscle Relaxant Drugs Market Breakdown By Type, $M (2015-2020)
Table 31 Asia Muscle Relaxant Drugs Market Breakdown By Country, $M (2011-2014)
Table 32 Asia Muscle Relaxant Drugs Market Breakdown By Country, $M (2015-2020)
Table 33 Row Muscle Relaxant Drugs Market Breakdown By Type, $M (2011-2014)
Table 34 Row Muscle Relaxant Drugs Market Breakdown By Type, $M (2015-2020)
Table 35 F. Hoffmann-La Roche Ltd-Key Facts
Table 36 Johnson & Johnson-Key Facts
Table 37 Glaxosmithkline Plc-Key Facts
Table 38 Intas Pharmaceuticals Ltd.-Key Facts
Table 39 Pfizer Inc.-Key Facts
Table 40 Galderma S.A.-Key Facts
Table 41 Merck & Co., Inc.-Key Facts

List Of Figures

Fig 1 Research Scope For Global Muscle Relaxant Drugs Market
Fig 2 Research Methodology For Global Muscle Relaxant Drugs Market
Fig 3 Applications Of Muscle Relaxants
Fig 4 Categories Of Skeletal Muscle Relaxants And Their Major Drugs
Fig 5 Types Of Neuromuscular Blocking Agents
Fig 6 Types Of Depolarizing Neuromuscular Blocking Agents, By Time Of Action
Fig 7 Usage Of Muscle Relaxants In Facial Aesthetics
Fig 8 Aging Population As A Percentage Of Total Population In Major Countries
Fig 9 Basic Drug Development Procedure
Fig 10 Global Muscle Relaxant Drugs Market Size, $M (2011-2020)
Fig 11 Global Muscle Relaxant Drugs Market Size By Type, $M (2011-2020)
Fig 12 Global Muscle Relaxant Drugs Market Size By Geography, $M (2011-2020)
Fig 13 Global Facial Aesthetic Relaxants Market Size, $M (2011-2020)
Fig 14 Global Facial Aesthetic Muscle Relaxant Drugs Market Share, By Region (2014 And 2020)
Fig 15 Global Facial Aesthetic Muscle Relaxants Market Size By Geography, $M (2011-2020)
Fig 16 Global Facial Aesthetic Muscle Relaxants Market Size By Drug, $M (2011-2020)
Fig 17 Global Skeletal Muscle Relaxants Market Size, $M (2011-2020)
Fig 18 Global Skeletal Muscle Relaxants Market Share, By Geography (2014 And 2020)
Fig 19 Global Skeletal Muscle Relaxants Market Size By Geography, $M (2011-2020)
Fig 20 Global Skeletal Muscle Relaxants Market Size By Drug, $M (2011-2020)
Fig 21 Global Neuromuscular Blocking Agents Market Size, $M (2011-2020)
Fig 22 Global Neuromuscular Blocking Agents Market Share, By Geography (2014 And 2020)
Fig 23 Global Neuromuscular Blocking Agents Market Size By Geography, $M (2011-2020)
Fig 24 Global Neuromuscular Blocking Agents Market Size By Type, $M (2011-2020)
Fig 25 Global Muscle Relaxant Drugs Market Size, By Country
Fig 26 North America Muscle Relaxant Drugs Market Size, $M (2011-2020)
Fig 27 North America Muscle Relaxant Drugs Market Share, By Type (2014 And 2020)
Fig 28 North America Muscle Relaxant Drugs Market Share, By Country (2014)
Fig 29 Europe Muscle Relaxant Drugs Market Size, $M (2011-2020)
Fig 30 Europe Muscle Relaxant Drugs Market Share, By Type (2014 And 2020)
Fig 31 Europe Muscle Relaxant Drugs Market Share, By Country (2014)
Fig 32 Asia Muscle Relaxant Drugs Market Size, $M (2011-2020)
Fig 33 Asia Muscle Relaxant Drugs Market Share, By Type (2014 And 2020)
Fig 34 Asia Muscle Relaxant Drugs Market Share, By Country (2014)
Fig 35 Row Muscle Relaxant Drugs Market Size, $M (2011-2020)
Fig 36 Row Muscle Relaxant Drugs Market Share, By Type (2014 And 2020)
Fig 37 Porter’S Five Forces Of Competitive Position Analysis
Fig 38 Market Share Of Key Players In The Global Muscle Relaxant Drugs Market (2014)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll